Digoxin may shorten the lives of patients with atrial fibrillation and the findings are prompting some experts to warn that the drug should be prescribed less widely. New York Times, 08/11/2014. (Also see: Cardiac Involvement)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.